51ÔÚÏß

In this free webinar, gain insights into emerging cardiovascular devices and their potential to redefine the trajectory of heart failure, including neuromodulation in heart disease, interventions for heart failure and structural and valvular heart disease. Leading cardiovascular experts will delve into the realm of cardiovascular devices, assessing their potential to redefine the trajectory of heart failure, ultimately aiming to keep individuals out of the hospital and on a stable plateau for extended periods.

TORONTO, Feb. 22, 2024 /PRNewswire-PRWeb/ -- In recent years, significant strides have been made in cardiovascular pharmacotherapy. Moving beyond the pillars of pharmacological heart failure treatment, a new frontier has emerged. In this upcoming webinar, leading cardiovascular experts delve into the realm of cardiovascular devices, assessing their potential to redefine the trajectory of heart failure, ultimately aiming to keep individuals out of the hospital and on a stable plateau for extended periods.

Join the featured speakers as they showcase groundbreaking devices with transformative potential:

•     Neuromodulation in heart disease: Highlighting innovative applications from baroreceptor activation therapy to cardiac pulmonary nerve stimulation
•     Interventions for heart failure: Showcasing devices for reverse remodeling, including electrical and physical remodeling devices, shunt devices and decongestion devices
•     Structural and valvular heart disease: Focusing on the prevalence of valvular heart disease and exploring catheter-based interventions for aortic, mitral and tricuspid valves — emphasizing the therapeutic potential in mitigating aortic and mitral regurgitation as well as addressing severe tricuspid regurgitation

This exploration of leading-edge cardiovascular devices aims to provide a holistic understanding of their potential impact on heart failure management and introduce a new era of personalized and effective cardiovascular care. Join this webinar as the featured speakers navigate the frontier of innovation in cardiovascular device development and strive to enhance patient outcomes and quality of life.

Join experts from , Dean J. Kereiakes, MD, FACC, MSCAI, Vice-President, Medical Department; Adam M. Lubert, MD, Medical Department; and Aung Myat, MRCP, MD, FACC, FESC, Medical Department, for the on Thursday, March 14, 2024, at 10am EDT (3pm CET/EU-Central).

For more information, or to register for this event, visit .

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit
For information about hosting a webinar visit

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, ,

SOURCE Xtalks